Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 208036
Company: BRACCO
Company: BRACCO
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
E-Z-CAT DRY | BARIUM SULFATE | 40% (9GM/POUCH) | FOR SUSPENSION;ORAL | Discontinued | None | Yes | No |
E-Z-HD | BARIUM SULFATE | 98% (334GM/BOT) | FOR SUSPENSION;ORAL | Prescription | None | Yes | Yes |
E-Z-PAQUE | BARIUM SULFATE | 96% (169GM/BOT) | FOR SUSPENSION;ORAL | Prescription | None | Yes | Yes |
VARIBAR THIN LIQUID | BARIUM SULFATE | 81% (120GM/BOT) | FOR SUSPENSION;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/11/2016 | ORIG-1 | Approval | Type 7 - Drug Already Marketed without Approved NDA | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208036s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208036Orig1s000Approvedt.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208036Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/30/2019 | SUPPL-10 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208036s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/208036Orig1s010ltr.pdf | |
02/08/2017 | SUPPL-6 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208036s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208036Orig1s006ltr.pdf | |
04/07/2017 | SUPPL-5 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208036s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208036Orig1s005ltr.pdf | |
01/03/2017 | SUPPL-2 | Efficacy-New Dosing Regimen |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208036s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208036Orig1s002ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
04/30/2019 | SUPPL-10 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208036s010lbl.pdf | |
04/07/2017 | SUPPL-5 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208036s005lbl.pdf | |
02/08/2017 | SUPPL-6 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208036s006lbl.pdf | |
02/08/2017 | SUPPL-6 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208036s006lbl.pdf | |
01/03/2017 | SUPPL-2 | Efficacy-New Dosing Regimen | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208036s002lbl.pdf | |
01/11/2016 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208036s000lbl.pdf |